Literature DB >> 1486674

Long-term efficacy of single-dose mass treatment with diethylcarbamazine citrate against diurnally subperiodic Wuchereria bancrofti: eight years' experience in Samoa.

E Kimura1, G F Spears, K I Singh, W A Samarawickrema, L Penaia, P F Sone, S Pelenatu, S T Faaiuaso, L S Self, B C Dazo.   

Abstract

A single-dose of diethylcarbamazine citrate (DEC, 6 mg per kg body weight) was administered in three mass treatment campaigns to > 80% of the estimated total Samoan population (160,000) in 1982, 1983, and 1986. The effect of the drug was evaluated before and after each campaign by conducting four blood surveys covering 9600 to 13,700 people from 26-34 villages on each occasion. The drug reduced the prevalence of Wuchereria bancrofti microfilariae from 5.6% to 2.5% (a 55% reduction), while the transmission potential (the estimated mosquito infection rate if everyone is equally exposed to mosquito bites) dropped from 2.18 to 0.67 (a 70% reduction). The total number of microfilariae in the Samoan population is estimated to have been reduced by 80%. A spaced, single-dose treatment with DEC at a 1-2-year interval therefore seems to be an effective control measure against diurnally subperiodic W. bancrofti.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486674      PMCID: PMC2393416     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  18 in total

1.  A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.

Authors:  B M Greene; Z D Dukuly; B Muñoz; A T White; M Pacqué; H R Taylor
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

2.  Diethylcarbamazine prophylaxis against bancroftian filariasis given by a member of the local community in Kenya.

Authors:  D J Wijers; N Kaleli; A H Ngindu
Journal:  Ann Trop Med Parasitol       Date:  1988-08

3.  [Progress in the use of diethylcarbamazine in the drug therapy of lymphatic filariasis caused by Wuchereria bancrofti var. pacifica: administration in widely spaced doses].

Authors:  J Laigret; G Fagneaux; E Tuira
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

4.  Diethylcarbamazine medicated salt in the chemotherapeutic control of filariasis due to Wuchereria bancrofti in an open community.

Authors:  A B Sen; R Chandra; J C Katiyar; S Chandra
Journal:  Indian J Med Res       Date:  1974-08       Impact factor: 2.375

5.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

6.  Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti.

Authors:  S Diallo; M A Aziz; O Ndir; S Badiane; I B Bah; O Gaye
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

7.  [Studies of the numerical distribution of microfilariae in foci of lymphatic filariasis (author's transl)].

Authors:  G Pichon; M Merlin; G Fagneaux; F Riviére; J Laigret
Journal:  Tropenmed Parasitol       Date:  1980-06

8.  Natural infections of Wuchereria bancrofti in Aedes (Stegomyia) polynesiensis and Aedes (Finlaya) samoanus in Samoa.

Authors:  W A Samarawickrema; F Sone; R F Cummings
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

9.  [A study of ivermectin in the treatment of lymphatic filariasis due to Wuchereria bancrofti var. pacifica in French Polynesia].

Authors:  J Roux; P Perolat; J L Cartel; J P Boutin; Y Sechan; M Larivière; M A Aziz
Journal:  Bull Soc Pathol Exot Filiales       Date:  1989-01

10.  Low-density microfilaraemia in subperiodic bancroftian filariasis in Samoa.

Authors:  E Kimura; L Penaia; W A Samarawickrema; G F Spears
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

View more
  6 in total

1.  The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji.

Authors:  Eisaku Kimura
Journal:  Trop Med Health       Date:  2011-03-24

2.  Filariasis control with diethylcarbamazine in three major endemic areas in Japan.

Authors:  Isao Tada
Journal:  Trop Med Health       Date:  2011-03

3.  Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.

Authors:  Pamela J Hooper; Brian K Chu; Alexei Mikhailov; Eric A Ottesen; Mark Bradley
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

4.  The global programme to eliminate lymphatic filariasis: health impact after 8 years.

Authors:  Eric A Ottesen; Pamela J Hooper; Mark Bradley; Gautam Biswas
Journal:  PLoS Negl Trop Dis       Date:  2008-10-08

5.  Defining the cost of the Egyptian lymphatic filariasis elimination programme.

Authors:  Reda M R Ramzy; Ann S Goldman; Hussein A Kamal
Journal:  Filaria J       Date:  2005-08-02

6.  The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).

Authors:  Hugo C Turner; Alison A Bettis; Brian K Chu; Deborah A McFarland; Pamela J Hooper; Eric A Ottesen; Mark H Bradley
Journal:  Infect Dis Poverty       Date:  2016-05-24       Impact factor: 4.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.